Search This Blog

Thursday, June 12, 2025

‘Japanese walking’ trend may be better than 10,000 steps

 Americans love to say they’re too busy to break a sweat — but a viral fitness trend is blowing that excuse out of the water. 

Enter “Japanese walking,” a simple, science-backed exercise routine that promises serious gains in just 30 minutes. 

“All movement is medicine, but if you’re short on time or want to get the most bang for your buck, this is for you,” strength training coach Eugene Teo said in a recent TikTok.

A majority of Americans don’t meet the CDC’s weekly exercise recommendations.bignai – stock.adobe.com

It’s long been said that taking 10,000 steps per day is the key to better health, with research linking regular walking to improved cardiovascular fitness, improved sleep quality and even a lower dementia risk.

But that magic number isn’t rooted in science. Instead, it originated from a marketing campaign to promote a Japanese pedometer in the 1960s.

And let’s be real, carving out the two hours it takes to hit that mark isn’t going to happen for most Americans. In surveys, nearly half say they’re too busy with work and other obligations to exercise at all.

Japanese walking might be the solution, offering a more efficient way to achieve the health benefits typically linked to 10,000 steps a day in a fraction of the time.

In a 2007 study, Japanese researchers recruited 246 adults with an average age of 63 and divided them into three groups.

One group did no walking at all. Another group walked at a steady, moderate pace, aiming for 8,000 or more steps a day at least four times per week.

It takes the average person between 1.75 and 2.5 hours to walk 10,000 steps.oasisamuel – stock.adobe.com
The third group practiced interval walking by walking slowly for three minutes, then walking quickly at a hard effort for three minutes. They repeated this cycle for 30 minutes, four or more days per week.

Researchers found that interval walking was superior to continuous walking for improving blood pressure, blood glucose levels and body mass index.

It also led to the greatest improvements in leg muscle strength and aerobic capacity, which measures the maximum amount of oxygen the body can take in and use during exercise.

The low-impact regimen might even hold the key to staying in shape as you get older.

longer-term study found that the Japanese walking method helps protect against the decline in strength and fitness that naturally occurs with aging.

Japanese walking can be tailored to fit all fitness levels.lordn – stock.adobe.com
Interval walking is “one of the most overlooked yet incredibly effective tools for improving long-term health, especially among middle-aged and older adults,” Dr. Ramit Singh Sambyal, a general physician, told Verywell Health

“By simply alternating between short periods of brisk walking and slower-paced recovery, we engage the cardiovascular system in a much more dynamic way,” he added. 

Another perk: Completing the 30-minute Japanese walking routine four times a week puts you just thirty minutes short of the CDC’s recommendation that adults get at least 150 minutes of moderate-intensity aerobic activity per week.

Add just one more walking session, or incorporate one of these 30-minute workouts, and you’ll be among the few Americans who actually hit that target.

Interval walking may be more effective than traditional walking for improving cardiovascular fitness.bongkarn – stock.adobe.com

Tips and tricks to master Japanese walking

To make sure you’re hitting the right pace, use a fitness tracker that measures your heart rate.

During those three minutes of brisk walking, aim for 70% to 85% of your maximum heart rate. When you slow down, let it drop to 40% to 50%.

No tracker? No problem. Try the “talk test.” At a brisk pace, you should be able to say a few words but need to catch your breath quickly. At a leisurely pace, you should be able to chat comfortably.

And if you’re worried about keeping up a brisk pace for a full three minutes, experts say it’s okay to start small.

“Try walking at your regular pace for a few minutes, then pick up the speed for 20 to 30 seconds, and repeat,” Dr. Sarah F. Eby, a sports medicine specialist, told Healthline

“As your body adapts to this new exercise stimulus, you can gradually increase the duration of the faster walking bouts,” she added. 

https://nypost.com/2025/06/12/health/japanese-walking-trend-may-be-better-than-10000-steps-a-day/

NYPD vehicles torched in suspected arson attack as cops find undetonated explosive

 Arsonists torched at least eight NYPD vehicles in a targeted attack in a Brooklyn parking lot early Thursday — with undetonated explosive devices also found after two masked suspects were seen running away, police and sources said.

Police and FDNY responded to a report of multiple vehicles ablaze at a lot in Bushwick at the intersection of Central and DeKalb avenues — just a block from the 83rd Precinct station house — around 1:30 a.m. Thursday.

Six marked vehicles and two unmarked vehicles were damaged, cops and sources said. No injuries were reported.

Officials at the scene of the suspected arson.Kyle Mazza
The vehicles were burned at a lot in Bushwick, Brooklyn.Kyle Mazza

Cops also discovered possible explosive devices that did not go off, soon after two people wearing masks and gloves were seen fleeing the lot, sources said. 

Photos from the scene obtained by The Post show four small spheres with wicks sticking out placed above a car tire.

The NYPD did not immediately give a suspected motive for the attack.

However, it comes as anti-ICE protesters have started running wild in the city, with some brazenly admitting they would set fire to police cars, similar to disturbing scenes in the riots in Los Angeles.

Although no connection has yet to be made by cops, the attack was celebrated by protesters — with one walking by the scene early Thursday calling it “awesome” and “f–king rad.”

One who was at the scene early Thursday morning told The Post that they thought the arson was “awesome” and “f–king rad.”

Eight vehicles were damaged in the attack.Kyle Mazza
Among the damaged vehicles were six marked cars.Kyle Mazza
“Burn more police cars, set more sh-t on fire, do things that actually matter and circumvent the police instead in the street and yelling ‘No, no, no!’” said the self-styled protest “supporter.”

The passerby, only giving the name Dylan, said it was a “tangible good” that more cop cars will be off the street.

When asked how the car burning makes protesters feel, Dylan said he “can’t speak for everyone” but “hopes everyone is excited.”

https://nypost.com/2025/06/12/us-news/nypd-vehicles-burned-in-suspected-arson-attack-in-brooklyn/

Nvidia CEO says Huawei has everyone ‘covered’ if US chip ban on China stays

 Still, Jensen Huang says his company's technology remains a generation ahead of those developed by Chinese rivals

Nvidia founder and CEO Jensen Huang said his company's technology remained a generation ahead of those developed by China, but warned that Huawei Technologies was in a position to expand its semiconductor business should US chip export curbs stay in place.

In an interview with US broadcaster CNBC on Thursday, Huang appeared to echo recent published remarks made by Huawei founder and CEO Ren Zhengfei, who said the Chinese company's Ascend artificial intelligence (AI) processors lagged behind those from the US "by a generation".

Ren, however, added that using methods like "stacking and clustering [on Ascend-powered machines], the computing results are comparable" to the most advanced systems in the world.

Do you have questions about the biggest topics and trends from around the world? Get the answers with SCMP Knowledge, our new platform of curated content with explainers, FAQs, analyses and infographics brought to you by our award-winning team.

"AI is a parallel problem, so if each one of the computers are not capable ... just add more computers," Huang said in response to a question about Ren's comments. "What he's saying is that in China, [where] they have plenty of energy, they'll just use more chips."

"He was saying that China's technology is good enough for China. If the United States doesn't want to participate in China, Huawei has got China covered," Huang added. "Huawei [also] has got everybody else covered."

The 62-year-old Nvidia CEO's televised comments, made on the sidelines of the annual VivaTech conference in Paris, reflect his concerns about Huawei's growing AI chip capabilities, which he earlier raised during a closed-door meeting last month with the US House of Representatives Foreign Affairs Committee.

In an interview with CNBC last month, Huang described Huawei's transformation into "one of the most formidable technology companies in the world", following the Chinese firm's progress in recent years with "essential capabilities to advance AI".

Huawei Technologies founder and CEO Ren Zhengfei. Photo: AFP

Following his keynote at the Computex 2025 trade show in Taipei last month, Huang said in an interview with tech site Stratechery that the US government's latest restrictions on Nvidia's H20 processors - which had been the most advanced chips the firm could sell to China since early 2024 - as "deeply painful", highlighting the substantial costs for his company and the broader impact on the AI ecosystem in the long run.

Huang told CNBC on Thursday that China remains a strategically important market for the US given the deep pool of AI talent in the world's second-largest economy.

"If we want the American technology stack to win around the world, then giving up 50 per cent of the world's AI researchers is not sensible," he said. "When China starts to aggressively diffuse their AI technology ... so long as all the AI developers are in China ... I think China's stack is going to win."

At VivaTech, Nvidia is trying to woo European markets with new partnerships and a pledge to build 20 new AI factories across the continent, as the company's sales in China shrink owing to Washington's tightening export controls.

Earlier this month, a report by digital publication The Information said Nvidia was developing a new China-tailored AI processor that complies with US export regulations and would enable users to link multiple units to create high-performance computing clusters.

Nvidia planned to produce more than 1 million units of its new B30 chip this year, the report said, amid efforts by the company to preserve its market share in China.

https://www.msn.com/en-xl/news/other/tech-war-nvidia-ceo-says-huawei-has-everyone-covered-if-us-chip-ban-on-china-stays/ar-AA1GAFZa

Cardinal Health Boosts Earnings Forecast: Unveils $10B Cash Flow, Growth Strategy

Cardinal Health (CAH) announced updated financial guidance and strategic plans at its Investor Day. The company raised its FY25 non-GAAP EPS guidance to $8.15-$8.20 and provided preliminary FY26 EPS guidance of $9.10-$9.30, representing 13% growth. CAH raised long-term profit growth targets for its Pharmaceutical and Specialty Solutions segment to 5-7% and Other segment to ~10%. The company expects to generate at least $10B in adjusted free cash flow over the next three years and increased its baseline share repurchase to $750M annually. Strategic initiatives include launching The Specialty Alliance MSO platform, expanding Biopharma Solutions, investing in distribution infrastructure, and continuing the GMPD Improvement Plan. The company also plans significant investments in Nuclear and Precision Health Solutions and at-Home Solutions expansion.

Kura, Kyowa Groundbreaking AML Trial: Ziftomenib 93% Complete Remission in Blood Cancer

Kura Oncology and Kyowa Kirin reported positive Phase 1a/1b trial results for ziftomenib combined with 7+3 chemotherapy in newly diagnosed AML patients. The KOMET-007 trial showed impressive complete remission rates of 93% in NPM1-mutant and 89% in KMT2A-rearranged AML patients. Notable MRD-negativity rates were achieved: 71% in NPM1-m and 88% in KMT2A-r patients. The treatment demonstrated favorable safety with no additive myelosuppression. High survival rates were observed with 96% of NPM1-m and 88% of KMT2A-r patients remaining alive and on study. Phase 3 studies (KOMET-017-IC and NIC) are planned to start in second half of 2025. The data suggests ziftomenib's potential as a frontline treatment option for AML patients.